DOES NEONATAL BCG GET MISSED IN A LOW-RISK POPULATION?
B Thyagarajan1, D Munro1 1 Paediatric Department, Harrogate District Hospital, Harrogate, UK Introduction: The prevalence of tuberculosis is rising. Data on monitoring of bacillus Calmette–Guérin (BCG) coverage in target groups is important but often lacking. In areas of high prevalence, BCG coverage is high. This audit was done to assess BCG coverage in babies born in a low-prevalence area. In the UK, neonatal BCG is offered to infants living in areas with tuberculosis incidence greater than 40/100 000; if parents/grandparents were born in a country with a tuberculosis incidence of more than 40/100 000; contacts of known cases; if intending to live in high-prevalence countries. Methods: North Yorkshire is a low-prevalence area (2.8 per 100 000 in 2006) for tuberculosis. The need for BCG is identified antenatally by the booking midwife. We reassessed the risk by interviewing mothers in the postnatal ward at Harrogate District Hospital. Booking notes were reviewed. Results: Between 2 an